# Merck and Eisai Provide Update on Phase 3 LITESPARK-012 Trial Evaluating First-Line Combination Treatments for Certain Patients With Advanced Renal Cell Carcinoma (RCC)

- URL: https://theranews.net/blog/2026-04-21-merck-and-eisai-provide-update-on-phase-3-litespark-012-trial-evaluating-first-l-a47567/
- Published: 2026-04-21
- Type: Archive summary (AI-assisted summary of third-party reporting)
- Original outlet: rutlandherald
- Original report: https://www.rutlandherald.com/news/business/merck-and-eisai-provide-update-on-phase-3-litespark-012-trial-evaluating-first-line-combination/article_96229ead-e9d2-5749-beb3-16a5a1fe1a0f.html
- Topics: anxiety
- Publisher: TheraNews, operated by AdvancedCare USA Inc.
- Notice: Educational content, not medical, legal, billing or financial advice. Cite the original outlet, not this summary.

> RAHWAY, N.J. & NUTLEY, N.J.--(BUSINESS WIRE)--Apr 21, 2026--

---
![Merck and Eisai Provide Update on Phase 3 LITESPARK-012 Trial Evaluating First-Line Combination Treatments for Certain Patients With Advanced Renal Cell Carcinoma (RCC)](/uploads/news-images/merck-and-eisai-provide-update-on-phase-3-litespar-20260421230036.jpg)

---
*Originally reported by rutlandherald. [Read more](https://www.rutlandherald.com/news/business/merck-and-eisai-provide-update-on-phase-3-litespark-012-trial-evaluating-first-line-combination/article_96229ead-e9d2-5749-beb3-16a5a1fe1a0f.html)*

---

*Source: [https://www.rutlandherald.com/news/business/merck-and-eisai-provide-update-on-phase-3-litespark-012-trial-evaluating-first-line-combination/article_96229ead-e9d2-5749-beb3-16a5a1fe1a0f.html](https://www.rutlandherald.com/news/business/merck-and-eisai-provide-update-on-phase-3-litespark-012-trial-evaluating-first-line-combination/article_96229ead-e9d2-5749-beb3-16a5a1fe1a0f.html)*